Richardson Electronics, Ltd. — FY2024 Form 10-K
Reporting period: Fiscal year ended June 1, 2024 (53 weeks), compared with the 52-week fiscal year ended May 27, 2023. The company is a global manufacturer, distributor and service provider across power and microwave technologies, green energy, customized displays and healthcare imaging. This is an annual filing; the company’s fiscal fourth-quarter results are also noted below.
Financial performance and liquidity
| Metric | FY2024 | FY2023 |
|---|---|---|
| Net sales | $196.5 million | $262.7 million |
| Gross profit / margin | $60.0 million / 30.5% | $83.7 million / 31.9% |
| SG&A | $59.5 million | $58.7 million |
| Operating income | $0.3 million | $25.0 million |
| Net income | $0.1 million | $22.3 million |
| Operating cash flow | $6.5 million | $(8.2) million |
| Capital expenditures | $4.0 million | $7.4 million |
| Cash and cash equivalents at year-end | $24.3 million | $25.0 million |
- Gross margin fell 1.4 percentage points. SG&A increased 1.4% in dollars but rose to 30.3% of sales from 22.4%, as lower revenue reduced operating leverage. Net margin was approximately 0.03% in FY2024.
- Cash from operations less capital expenditures was approximately $2.5 million. Operating cash flow benefited from lower receivables, partly offset by a decline in accounts payable.
- Current assets were $161.7 million and current liabilities $32.0 million. Inventory was $110.1 million, net of a $6.0 million reserve; inventory remained a large share of current assets.
- No borrowings were outstanding at year-end under the $30 million secured revolving facility, which matures in March 2026. The company drew and repaid $3.7 million during FY2024 and reported compliance with facility covenants.
- Dividends paid were $3.4 million; the quarterly dividend was $0.06 per common share and $0.054 per Class B share. Future dividends remain at the board’s discretion.
Material changes and segment trends
- Sales declined 25.2% year over year. PMT sales fell 21.7% to $128.7 million, mainly due to lower semiconductor wafer-fabrication and RF/microwave demand. GES fell 51.2% to $23.2 million, reflecting project timing, delayed EV locomotive shipments and a large battery-module shipment in FY2023 that did not recur. Canvys fell 17.5% to $32.4 million, including weaker North American medical OEM demand amid high interest rates. Healthcare rose 5.7% to $12.1 million on higher parts and CT-tube sales.
- Segment gross margins were 30.1% for PMT, 28.4% for GES, 33.8% for Canvys and 30.4% for Healthcare. Consolidated margin pressure primarily reflected product mix and manufacturing under-absorption in PMT and Healthcare.
- North America sales declined 31.1% to $77.3 million; Asia/Pacific declined 24.0% to $45.3 million; Europe was down 0.9% to $61.5 million; and Latin America declined 62.3% to $10.9 million. Approximately 60% of FY2024 sales were outside the United States.
- Fiscal 2024 quarterly sales were $52.6 million, $44.1 million, $52.4 million and $47.4 million, respectively. Quarterly net income was $1.2 million, a loss of $1.8 million, $0.8 million and a loss of $0.1 million, respectively.
Outlook, risks and unusual items
- The filing provides no quantified FY2025 revenue, earnings or margin guidance. Management stated that existing liquidity and expected operating cash flows should meet known capital and working-capital needs for at least the next 12 months. Management also cited market-share gains in PMT and GES, while describing demand and results as exposed to market cycles and project timing.
- Key risks include further semiconductor-market weakness; project delays or cancellations; inventory obsolescence and demand-forecasting risk; dependence on a limited number of suppliers (two each represented 11% of cost of sales); supply-chain and logistics disruption; customer credit risk; and competition and pricing pressure.
- International operations expose the company to foreign-exchange movements, tariffs, geopolitical events and regulatory requirements. The company does not use currency derivatives; a hypothetical 10% unfavorable dollar movement was estimated to reduce FY2024 foreign-currency-denominated sales by $10.8 million. Proposed U.S. tariff changes on certain Chinese products were not expected by management to materially affect the company.
- The FY2024 income-tax provision was $0.1 million, with a 61.4% effective tax rate on low pretax income. Tax-rate effects included valuation-allowance changes and other jurisdictional items; the company recorded $0.5 million of expected federal R&D credits and increased its valuation allowance on state net operating losses.
- BDO USA, P.C. issued an unqualified audit opinion on the financial statements and internal controls. The auditor identified estimation of the PMT inventory reserve as a critical audit matter; no separate audit opinion was expressed on that matter. Management reported effective disclosure controls and internal control over financial reporting.
Important facts for investors to verify
- Whether PMT’s semiconductor and RF demand recovers, and whether GES customer delays and project timing improve.
- Inventory quality, aging and reserve adequacy, particularly for PMT trailing-edge products; inventory reserve estimates are judgment-sensitive.
- Whether cash generation and gross margins improve enough to support the current cost base and dividends.
- Actual effects of proposed tariffs, foreign-exchange movements and supplier concentration on costs, demand and margins.
- Future use and covenant capacity of the secured revolving credit facility, as well as the company’s ability to sustain liquidity if operating results weaken.
- The implications of voting control: the CEO beneficially owned approximately 61% of voting power as of July 26, 2024.